Latanoprost 0.005% in POAG: Effects on IOP and ocular blood flow

Acta Ophthalmologica Scandinavica, Supplement

Volumn 76, Issue 227, 1998, Pages 40-41

  Vetrugno, M ^a   Cantatore, F ^a   Gigante, G ^a   Cardia, L ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Glaucoma; Latanoprost; Ocular blood flow

Indexed keywords

LATANOPROST; TIMOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; EYE DROPS; PROSTAGLANDIN F;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFICACY; EYE BLOOD FLOW; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; OPTIC NERVE; PRIORITY JOURNAL; TIME; TOPICAL DRUG ADMINISTRATION; ARTICLE; BLOOD FLOW VELOCITY; CHOROID; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; FOLLOW UP; MIDDLE AGED; PATHOPHYSIOLOGY; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; VASCULARIZATION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; BLOOD FLOW VELOCITY; CHOROID; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSTAGLANDINS F, SYNTHETIC; SINGLE-BLIND METHOD; TIMOLOL; TREATMENT OUTCOME;

EID: 0032216722     PISSN: 13953931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Alm A, Camras CB & Watson PG (1997): Phase III Latanoprost studies in Scandinavia, the United Kingdom and the United States. Surv Ophthalmol 41: S105.
2. Forstermann U, Mugge A, Bode SM, et al. (1988): Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids. Circ Res 63: 306.
3. Langham ME (1987): Ocular blood flow and visual loss in glaucomatous eyes. In: Krieglestein GK (ed.) Glaucoma Update III. Heidelberg: Springer-Verlag, 58-66.
4. Morsman CD, Bosem ME, Lusky M & Weinreb RN (1993): The effect of topical beta-adrenoceptor blocking agents on pulsatile ocular blood flow. Eye 9: 344.
5. Rulo AH & Hoyng PhFJ (1996): Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma. Ophthalmology 103: 1276.
6. Stjernschantz J & Alm A (1996): Latanoprost as a new horizon in the medical management of glaucoma. Curr Opin Ophthalmol 2: 11.